The composition difference is a fact worth knowing. The claim that one suits calm skin and the other suits inflamed skin rests on nothing, because neither blend has ever been studied.
An open study found sleep normalised in six of seven patients. The controlled study by the same investigator found weak effects and said so. The difference between them is a placebo arm.
It does not raise dopamine — it magnifies what other things do to it. That one property explains why caffeine feels stronger on it, and why MAO inhibitors are a hard contraindication.
For most research peptides there is no long-term human safety record. Not a poor one — an absent one. Here is what that means.
Five questions that separate evidence from marketing, none of which need a science background. Apply them to this site too.
Moisture, heat, light and oxygen, and what each one actually does. Plus the distinction that resolves most storage arguments: microbial safety and chemical stability are two different clocks.
Molecular size, a fifteen-minute clearance window, and a 150-microlitre ceiling decide it. Not formulation effort.
Not a peptide, never tested in a human, and sold at a fraction of the studied dose in a form that may not absorb. The mechanism is real; almost nothing else is settled.
A small molecule, not a peptide. It targets a drain on NAD+ that only exists in fat tissue — and only when that drain is already overexpressed.
Every fact here links to the study, official handbook, or regulator's own document it came from. If we are leaning on someone else's summary, we say so.
We report what has been measured and published. We never tell anyone what to take, how much, or why. Nothing here is medical advice.
When we get something wrong, we add the correction to the article with the date. We do not quietly edit the mistake away.
